Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Shanghai Pharmaceuticals Holding Co ( (HK:2607) ) has shared an announcement.
Shanghai Pharmaceuticals Holding Co., Ltd. announced an interim dividend of RMB 1.2 per 10 shares for the six months ending June 30, 2025, with payment to be made in Hong Kong dollars. The announcement includes details on withholding tax rates applicable to various shareholder categories, impacting both enterprise and individual non-resident shareholders. This move reflects the company’s ongoing commitment to shareholder returns and may influence investor sentiment positively.
The most recent analyst rating on (HK:2607) stock is a Buy with a HK$13.00 price target. To see the full list of analyst forecasts on Shanghai Pharmaceuticals Holding Co stock, see the HK:2607 Stock Forecast page.
More about Shanghai Pharmaceuticals Holding Co
Shanghai Pharmaceuticals Holding Co., Ltd. operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products. The company is a key player in the healthcare market, providing a range of medical and healthcare services.
Average Trading Volume: 3,061,652
Technical Sentiment Signal: Buy
Current Market Cap: HK$66.15B
See more insights into 2607 stock on TipRanks’ Stock Analysis page.